August 13, 2026 — The global dual energy X-ray absorptiometry (DEXA) market is valued at USD 1.4 billion in 2026, is projected to reach USD 2.8 billion by 2036, and is forecast to grow at a 7.1% CAGR from 2026 to 2036, according to Fact.MR. The market crossed USD 1.3 billion in 2025.

DEXA demand is rising as hospitals and imaging providers focus on repeatable bone-density assessment. Osteoporosis diagnosis creates repeat use because physicians need baseline readings and later treatment monitoring. Hospitals and imaging services also favor central systems when scan volumes require stable reporting. Detector replacement can add demand as facilities seek clearer images and easier workflows.

For manufacturers and healthcare buyers, system reliability is becoming a key purchase factor. Procurement teams can compare systems based on scan reliability, calibration stability, detector performance, service coverage, and workflow integration. Fact.MR identifies adoption and integration as having a +1.6% impact on CAGR, while cost and complexity has a -1.1% impact.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=15959

Third-Party Market Evidence

The supplied Fact.MR page does not provide 2–3 dated numerical statistics from named third-party sources. Because this release must use only information from the supplied page, no outside statistics have been added or inferred.

The page instead provides Fact.MR's own dated market figures and country forecasts. It also identifies adoption and integration, regulatory support, channel expansion, documentation, and efficiency as factors shaping market growth.

Key Numbers

Source: Fact.MR.

Segment Breakdown

Central DEXA Systems: Central DEXA Systems are expected to hold a 45.0% share in 2026, making them the leading system type. Fact.MR links this position to hospital use for higher-throughput bone-density assessment. Peripheral, portable, and multi-purpose systems serve lower-complexity or more flexible placement needs.

Osteoporosis Diagnosis: Osteoporosis Diagnosis is projected to account for 48.0% of the market in 2026. DEXA scans support fracture-risk review and treatment monitoring. Body Composition Analysis adds demand from wellness settings, while oncology and geriatric applications remain narrower specialist uses.

Hospitals: Hospitals are anticipated to capture a 44.0% share in 2026. Referrals and imaging review often occur within the same care system, supporting hospital demand. Diagnostic Imaging Centers, Academic Medical Centers, and Orthopedic Centers also contribute to demand.

Public Healthcare Providers: Public Healthcare Providers are estimated to represent 40.0% in 2026. Screening access and institutional purchasing coverage support this position. Diagnostic Service Providers, Research Organizations, and Orthopedic Specialists serve additional demand.

Digital Flat Panel Detectors: Digital Flat Panel Detectors are forecast to hold 42.0% in 2026. Fact.MR links their position to image quality and easier image handling.

Country CAGR Outlook

Source: Fact.MR country analysis.

USA: The USA leads the listed countries at 7.9% CAGR, supported by hospital purchasing depth and wider osteoporosis screening.

Japan: Japan follows at 7.6% CAGR, with aging-care pathways supporting demand for bone-health assessment and fracture-risk monitoring.

Germany: Germany is forecast to grow at 7.2% CAGR, supported by structured healthcare networks and disciplined equipment review.

Canada: Canada records 6.8% CAGR, driven by public healthcare access and regional imaging needs.

UK: The UK is projected to grow at 6.5% CAGR, supported by established clinical pathways and imaging service coverage.

Australia: Australia reaches 6.2% CAGR, backed by imaging-center demand and regional access planning.

South Korea: South Korea records 5.8% CAGR, supported by hospital imaging capacity and detector-led replacement.

Competitive Landscape

Fact.MR identifies Hologic, Inc.; GE HealthCare Technologies Inc.; FUJIFILM Healthcare; Swissray–Norland; OsteoSys Co., Ltd.; DMS Imaging–Medilink; Medonica Co., Ltd.; Xingaoyi Medical Equipment Co., Ltd.–XGY; and Canon Inc.–Canon Medical as key companies in the DEXA market.

Hologic has direct relevance to bone-density and body-composition assessment. GE HealthCare Technologies and FUJIFILM Healthcare bring wider medical imaging capabilities. Swissray–Norland, OsteoSys, DMS Imaging–Medilink, Medonica, XGY, and Canon Medical complete the named provider landscape.

Company-share limitation: The supplied page does not provide individual market-share percentages for the named companies. No company shares have therefore been invented.

Analyst Commentary

Shambhu Nath Jha, Principal Consultant at Fact.MR, states:

“DEXA systems must deliver repeatable bone-density readings and consistent image quality across hospital and diagnostic imaging workflows.”

The published commentary says procurement acceptance is expected to depend on calibration stability, detector reliability, and service responsiveness through repeated scan cycles rather than equipment price alone.

FAQ

What is the DEXA market size in 2026?
Fact.MR values the global DEXA market at USD 1.4 billion in 2026.

What will the DEXA market be worth in 2036?
The market is projected to reach USD 2.8 billion by 2036.

What is the DEXA market CAGR?
Fact.MR forecasts a 7.1% CAGR from 2026 to 2036.

Which DEXA system type has the largest share?
Central DEXA Systems lead with a 45.0% share in 2026.

Which country has the fastest DEXA market growth?
The USA leads the listed countries with a 7.9% CAGR through 2036.

About Fact.MR

Fact.MR provides market research and industry analysis covering market sizing, forecasts, segmentation, country analysis, competitive landscapes, and strategic business insights.